GLP-1 medications work by mimicking the naturally occurring hormone GLP-1, leading to improved blood sugar control and reduced appetite
Some evidence suggests dual agonists might better preserve lean body mass during weight loss, though this remains under investigation
Easy dosing: Inject GLP-1s with easy-to-use single-dose or multi-dose pens
It focuses on the mechanism of action of GLP-1R in pancreatic islet -cells, -cells and -cells, as well as its effects on the central nervous system and gastrointestinal tract
A novel glucagon-like peptide-1 (GLP-1)/Glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice
They also show promise for the treatment of many inflammatory diseases including asthma and inflammatory bowel disorders like Crohns disease and ulcerative colitis Diagram showing food stimulating the release of GLP-1 into the intestine and its effects on the brain, stomach and pancreas Importance In 2023 GLP-1 based drugs was named breakthrough of the year by Science , a prestigious American journal